Ons Harrabi
Impact in
- Ophthalmology top 5%
- Retinal Diseases and Treatments
- Immunology top 10%
- Phagocytosis and Immune Regulation
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Immunology 16
- Immunotherapy and Immune Responses 11
- Phagocytosis and Immune Regulation 6
- Complement system in diseases 4
- Immune cells in cancer 3
-
- Retinal Diseases and Treatments 3
- Co-authors
- Sangeetha BolliniJaume PonsJennifer H. LaVailTracy C. KuoAmy ChenHong WanAndrew N. TauscherEmma Sangalang
- Journals
- Cancer Research (3 papers)Investigative Ophthalmology & Visual Science (2 papers)Journal of Virology (2 papers)Blood (2 papers)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
Ons Harrabi
18 papers receiving 610 citations
Peers
Comparison fields: 5 of 64
- Ophthalmology 162
- Immunology 279
- Neurology 54
- Physiology 157
- Radiology, Nuclear Medicine and Imaging 105
Countries citing papers authored by Ons Harrabi
This map shows the geographic impact of Ons Harrabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ons Harrabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ons Harrabi more than expected).
Fields of papers citing papers by Ons Harrabi
This network shows the impact of papers produced by Ons Harrabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ons Harrabi. The network helps show where Ons Harrabi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ons Harrabi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 3 | |
| 7 | 2020 | 58 | |
| 8 | 2020 | 0 | |
| 9 | 2020 | 3 | |
| 10 | 2019 | 39 | |
| 11 | KSI-301: An anti-VEGF antibody biopolymer conjugate with extended half-life for treatment of neovascular retinal diseases | 2018 | 10 |
| 12 | 2018 | 121 | |
| 13 | 2018 | 17 | |
| 14 | 2017 | 8 | |
| 15 | 2011 | 78 | |
| 16 | 2011 | 175 | |
| 17 | 2007 | 50 | |
| 18 | 2005 | 26 | |
| 19 | 2004 | 1 | |
| 20 | 2003 | 22 |
About Ons Harrabi
Ons Harrabi is a scholar working on Immunology, Ophthalmology, Radiology, Nuclear Medicine and Imaging, Dermatology and Oncology, having authored 21 papers that have together received 626 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Phagocytosis and Immune Regulation (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Herpesvirus Infections and Treatments (4 papers), Complement system in diseases (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Immune cells in cancer (3 papers) and Retinal Diseases and Treatments (3 papers). The work is most often cited by research in Ophthalmology (162 citations), Immunology (279 citations), Neurology (54 citations), Physiology (157 citations) and Radiology, Nuclear Medicine and Imaging (105 citations). Ons Harrabi has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Sangeetha Bollini, Jaume Pons, Jennifer H. LaVail, Tracy C. Kuo, Amy Chen, Hong Wan, Andrew N. Tauscher, Emma Sangalang, Laura V. Doyle and Steven E. Kauder. Their work appears in journals such as Cancer Research, Investigative Ophthalmology & Visual Science, Journal of Virology, Blood and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.